Rubicon Research Limited (BOM:544578)
953.70
-4.30 (-0.45%)
At close: Apr 28, 2026
Rubicon Research Market Cap
Rubicon Research has a market cap or net worth of 157.29 billion as of April 28, 2026.
Market Cap
157.29B
Enterprise Value
161.45B
Revenue
15.98B
Ranking
n/a
PE Ratio
76.28
Stock Price
953.70
Market Cap Chart
Since October 16, 2025, Rubicon Research's market cap has increased from 103.50B to 157.29B, an increase of 51.97%. That is a compound annual growth rate of 120.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 157.95B | 40.84% |
| Dec 31, 2025 | 112.15B | 8.37% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rubicon Research | 154.65B |
| Jubilant Pharmova | 149.60B |
| Granules India | 170.76B |
| Caplin Point Laboratories | 130.50B |
| AstraZeneca Pharma India | 212.54B |
| CORONA Remedies | 99.90B |
| Viyash Scientific | 90.17B |
| Procter & Gamble Health | 85.33B |